I have been watching this for a while and have to agree. I see many companies in this biotech space keep chasing that deal with big pharma and it rarely happens. Unless there are multiple big pharma interested (i.e. an area of high unmet need) then even if someone was interested it isn't going to be super lucrative because Ivx is a distressed company. At least that is my take on it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.336M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 9.5¢ | $25.88K | 255.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 220 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 124684 | 4 |
View Market Depth
| Last trade - 15.59pm 30/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |